Makoto Nakashima1, Hasan Jilaihawi2. 1. Heart Valve Center, NYU Langone Health, 530 1st Avenue, Suite 9V, New York, NY, 10016, USA. 2. Heart Valve Center, NYU Langone Health, 530 1st Avenue, Suite 9V, New York, NY, 10016, USA. hasanjilaihawi@gmail.com.
Abstract
PURPOSE OF REVIEW: We review the pathology, prevalence, diagnosis, hemodynamics, risk factors, prognosis, and treatment of leaflet thrombosis (LT), and suggest future directions in this field. RECENT FINDINGS: The latest meta-analysis showed the prevalence of overall LT is 5.4% (clinical LT of 1.2% and subclinical LT of 15.1%). Either subclinical or clinical LT is not associated with risk of mortality; however, clinical LT is associated with increased risk of stroke. Although LT can be reduced by oral anticoagulation therapy (OAT), routine use of OAT as primary prevention for high-risk patients is not recommended due to increased risk of mortality. Four-dimensional computed tomography plays an important role in the diagnosis of LT and the accumulation of qualitative or qualitative assessments of hypoattenuated leaflet thickening would provide more clues to clarify effective OAT strategies. In addition, further studies are warranted to evaluate the efficacy of other anticoagulants in low-intermediate risk patients.
PURPOSE OF REVIEW: We review the pathology, prevalence, diagnosis, hemodynamics, risk factors, prognosis, and treatment of leaflet thrombosis (LT), and suggest future directions in this field. RECENT FINDINGS: The latest meta-analysis showed the prevalence of overall LT is 5.4% (clinical LT of 1.2% and subclinical LT of 15.1%). Either subclinical or clinical LT is not associated with risk of mortality; however, clinical LT is associated with increased risk of stroke. Although LT can be reduced by oral anticoagulation therapy (OAT), routine use of OAT as primary prevention for high-risk patients is not recommended due to increased risk of mortality. Four-dimensional computed tomography plays an important role in the diagnosis of LT and the accumulation of qualitative or qualitative assessments of hypoattenuated leaflet thickening would provide more clues to clarify effective OAT strategies. In addition, further studies are warranted to evaluate the efficacy of other anticoagulants in low-intermediate risk patients.
Authors: Raj R Makkar; Philipp Blanke; Jonathon Leipsic; Vinod Thourani; Tarun Chakravarty; David Brown; Alfredo Trento; Robert Guyton; Vasilis Babaliaros; Mathew Williams; Hasan Jilaihawi; Susheel Kodali; Isaac George; Michael Lu; James M McCabe; John Friedman; Richard Smalling; Shing Chiu Wong; Shahram Yazdani; Deepak L Bhatt; Jeroen Bax; Samir Kapadia; Howard C Herrmann; Michael Mack; Martin B Leon Journal: J Am Coll Cardiol Date: 2020-06-23 Impact factor: 24.094
Authors: Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Lee A Fleisher; Hani Jneid; Michael J Mack; Christopher J McLeod; Patrick T O'Gara; Vera H Rigolin; Thoralf M Sundt; Annemarie Thompson Journal: Circulation Date: 2017-03-15 Impact factor: 29.690
Authors: Jeffrey J Popma; G Michael Deeb; Steven J Yakubov; Mubashir Mumtaz; Hemal Gada; Daniel O'Hair; Tanvir Bajwa; John C Heiser; William Merhi; Neal S Kleiman; Judah Askew; Paul Sorajja; Joshua Rovin; Stanley J Chetcuti; David H Adams; Paul S Teirstein; George L Zorn; John K Forrest; Didier Tchétché; Jon Resar; Antony Walton; Nicolo Piazza; Basel Ramlawi; Newell Robinson; George Petrossian; Thomas G Gleason; Jae K Oh; Michael J Boulware; Hongyan Qiao; Andrew S Mugglin; Michael J Reardon Journal: N Engl J Med Date: 2019-03-16 Impact factor: 91.245
Authors: Michael J Mack; Martin B Leon; Vinod H Thourani; Raj Makkar; Susheel K Kodali; Mark Russo; Samir R Kapadia; S Chris Malaisrie; David J Cohen; Philippe Pibarot; Jonathon Leipsic; Rebecca T Hahn; Philipp Blanke; Mathew R Williams; James M McCabe; David L Brown; Vasilis Babaliaros; Scott Goldman; Wilson Y Szeto; Philippe Genereux; Ashish Pershad; Stuart J Pocock; Maria C Alu; John G Webb; Craig R Smith Journal: N Engl J Med Date: 2019-03-16 Impact factor: 91.245
Authors: Philipp Blanke; Jonathon A Leipsic; Jeffrey J Popma; Steven J Yakubov; G Michael Deeb; Hemal Gada; Mubashir Mumtaz; Basel Ramlawi; Neal S Kleiman; Paul Sorajja; Judah Askew; Christopher U Meduri; James Kauten; Serguei Melnitchouk; Ignacio Inglessis; Jian Huang; Michael Boulware; Michael J Reardon Journal: J Am Coll Cardiol Date: 2020-03-28 Impact factor: 24.094
Authors: Raj R Makkar; Gregory Fontana; Hasan Jilaihawi; Tarun Chakravarty; Klaus F Kofoed; Ole De Backer; Federico M Asch; Carlos E Ruiz; Niels T Olsen; Alfredo Trento; John Friedman; Daniel Berman; Wen Cheng; Mohammad Kashif; Vladimir Jelnin; Chad A Kliger; Hongfei Guo; Augusto D Pichard; Neil J Weissman; Samir Kapadia; Eric Manasse; Deepak L Bhatt; Martin B Leon; Lars Søndergaard Journal: N Engl J Med Date: 2015-10-05 Impact factor: 91.245
Authors: Hasan Jilaihawi; Federico M Asch; Eric Manasse; Carlos E Ruiz; Vladimir Jelnin; Mohammad Kashif; Hiroyuki Kawamori; Yoshio Maeno; Yoshio Kazuno; Nobuyuki Takahashi; Richard Olson; Joe Alkhatib; Daniel Berman; John Friedman; Norman Gellada; Tarun Chakravarty; Raj R Makkar Journal: JACC Cardiovasc Imaging Date: 2017-04
Authors: J L Liu; W N Zeng; F Y Wang; C Chen; X Y Gong; H Yang; Z J Tan; X L Jia; L Yang Journal: J Thromb Haemost Date: 2017-12-01 Impact factor: 5.824